Role of disrupted gap junctional intercellular communications in detection and characterization of carcinogens

Mutation Research - Reviews in Genetic Toxicology

Volumn 365, Issue 1-3, 1996, Pages 91-105

  Yamasaki, Hiroshi ^a  

^a Intl Agy for Res on C   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOGEN; GAP JUNCTION PROTEIN; PROTECTIVE AGENT;

ANIMAL CELL; CANCER RISK; CARCINOGENESIS; CELL COMMUNICATION; CELL GROWTH; GENOTOXICITY; HUMAN; HUMAN CELL; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; RAT; REVIEW; RISK ASSESSMENT; TUMOR PROMOTION;

ANIMALIA;

EID: 0030250227     PISSN: 01651110     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-1110(96)90014-7     Document Type: Article

References (107)

1. Asamoto M., Oyamada M., El Aoumari A., Gros D., Yamasaki H. Molecular mechanisms of TPA-mediated inhibition of gap junctional intercellular communication; evidence for action on the assembly or function but not the expression of connexin 43 in rat liver epithelial cells. Mol. Carcinogen. 4:1991;322-327.
2. Asamoto M., Takahashi S., Imaida K., Shirai T., Fukushima S. Increased gap junctional intercellular communication capacity and connexin 43 and 26 expression in rat bladder carcinogenesis. Carcinogenesis. 15:1994;2163-2166.
3. Ashby J., Tennant R.W. Definitive relationships among chemical structure, carcinogenicity and mutagenicity for 301 chemicals tested by the US NTP. Mutation Res. 257:1991;229-306.
4. Atkinson M.M., Menko A.S., Johnson R.G., Sheppard J.R., Sheridan J.D. Rapid and reversible reduction of junctional permeability in cells infected with a temperature-sensitive mutant of avian sarcoma virus. J. Cell Biol. 91:1981;573-578.
5. Azarnia R., Reddy S., Kmiecik T.E., Shalloway D., Loewenstein W.R. The cellular src gene product regulates junctional cell-to-cell communication. Science. 239:1988;398-401.
6. Bai S., Schoenfeld A., Pietrangelo A., Burk R.F. Basal promoter of the rat connexin 32 gene: identification and characterization of an essential element and its DNA-binding protein. Mol. Cell Biol. 15:1995;1439-1445.
7. Beer D.C., Neveu M.J., Paul D.L., Rapp U.R., et al. Expression of the c-raf protooncogene: (γ-glutamyltranspeptidase and gap junction protein in rat liver neoplasms. Cancer Res. 48:1988;1610-1617.
8. Bennett M.V.L., Barrio L.C., Bargiello T.A., Spray D.C., et al. Gap junctions: new tools, new answers, new questions. Neuron. 6:1991;305-320.
9. Berghoffen J., Scherer S.S., Wang S., Oronzi-Scott L.J., et al. Connexin mutation in X-linked Charcot-Marie-Tooth disease. Science. 262:1993;2039-2041.
10. Berthoud V.M., Rook M.B., Traub O., Hertzberg E.L., Saez J.C. On the mechanisms of cell uncoupling induced by a tumor promoter phorbol ester in clone 9 cells, a rat liver epithelial cell line. Eur. J. Cell Biol. 62:1993;384-396.
11. Beyer E.C. Gap junctions. Int. Rev. Cytol. 137C:1993;1-37.
12. Bond S.L., Bechberger J.F., Khoo N.K., Naus C.C. Transfection of C6 glioma cells with connexin 32: the effects of expression of a nonendogenous gap junction protein. Cell Growth Differ. 5:1994;179-186.
13. Britz-Cunningham S.H., Chan M.M., Zuppan C.W., Fletcher W.H. Mutations of the connexin 43 gap-junction gene in patients with heart malformations and defects of laterality. N. Engl. J. Med. 332:1995;1323-1329.
14. Bruzzone R., White T.W., Scherer S.S., Fischbeck K.H., Paul D.L. Null mutations of connexin 32 in patients with X-linked Charcot-Marie Tooth disease. Neuron. 13:1994;1253-1260.
15. Budunova I.V., Williams G.M. Cell culture assays for chemicals with tumor-promoting or tumor-inhibiting activity based on the modulation of intercellular communication. Cell Biol. Toxicol. 10:1994;71-116.
16. Chaumontet C., Bex V., Gaillard-Sanchez I., Seillan-Heberden C., et al. Apigenin and tangeretin enhance gap junctional intercellular communication in rat liver epithelial cells. Carcinogenesis. 15:1994;2325-2330.
17. Chen Z.Q., Lefebvre D., Bai X.H., Reaume A., et al. Identification of two regulatory elements within the promoter region of the mouse connexin 43 gene. J. Biol. Chem. 270:1995;3863-3868.
18. De Feijter A.W., Ray J.S., Weghorst C.M., Klaunig J.E., et al. Infection of rat liver epithelial cells with v-Ha-ras; correlation between oncogene expression, gap junctional communication and tumorigenicity. Mol. Carcinogen. 3:1990;54-67.
19. Eghbali B., Kessler J.A., Raid L.M., Roy C., Spray D.S. Involvement of gap junction in tumorigenesis: transfection of tumor cells with connexin 32 cDNA retards growth in vivo. Proc. Natl. Acad. Sci. USA. 88:1991;10701-10705.
20. Elfgang C., Eckert R., Lichtenberg-Frate H., Butterweck A., et al. Specific permeability and selective formation of gap junction channels in connexin-transfected HeLa cells. J. Cell Biol. 129:1995;805-817.
21. Enomoto T., Yamasaki H. Lack of intercellular communication between chemically-transformed and surrounding non-transformed BALB/c 3T3 cells. Cancer Res. 44:1984;5200-5203.
22. Enomoto T., Sasaki Y., Shiba Y., Kanno Y., Yamasaki H. Tumor promoters cause a rapid and reversible inhibition of the formation and maintenance of electrical cell coupling in culture. Proc. Natl. Acad. Sci. USA. 78:1981;5628-5632.
23. Enomoto T., Martel N., Kanno Y., Yamasaki H. Inhibition of cell-cell communication between BALB/c 3T3 cells by tumor promoters and protection by cAMP. J. Cell Physiol. 121:1984;323-333.
24. Esinduy C.B., Chang C.C., Trosko J.E., Ruch R.J. In vitro growth inhibition of neoplastically-transformed cells by non-transformed cells: requirement for gap junctional intercellular communication. Carcinogenesis. 16:1995;915-921.
25. Fairweather N., Bell C., Cochrane S., Chelly J., Wang S., et al. Mutations in the connexin 32 gene in X-linked dominant Charcot-Marie-Tooth disease (CMTX1). Hum. Mol. Genet. 3:1994;29-34.
26. Fearon E.R., Vogelstein B.A. A genetic model for colorectal tumorigenesis. Cell. 61:1990;759-767.
27. Fitzgerald D.J., Mesnil M., Oyamada M., Tsuda H., et al. Changes in gap junction protein (connexin 32) gene expression during rat liver carcinogenesis. J. Cell Biochem. 41:1989;97-102.
28. Goldberg G.S., Bertram J.S. Retinoids, gap junctional communication and suppression of epithelial tumors. In Vivo. 8:1994;745-754.
29. Goldberg G.S., Martyn K.D., Lau A.F. A connexin 43 antisense vector reduces the ability of normal cells to inhibit the foci formation of transformed cells. Mol. Carcinogen. 11:1994;106-114.
30. Grossman H.B., Liebert M., Lee I.W., Lee S.W. Decreased connexin expression and intercellular communication in human bladder cancer cells. Cancer Res. 54:1994;3062-3065.
31. Guguen-Guillouzo C., Clément B., Baffet G., Beaumont C., et al. Maintenance and reversibility of active albumin secretion by adult rat hepatocytes cocultured with another liver epithelial type. Exp. Cell Res. 143:1983;47.
32. IARC. Mechanisms of carcinogenesis in risk identification. IARC Internal Technical Report 91/002. 1991;. Lyon.
33. 2+ in mouse epidermal cells is controlled by E-cadherin. J. Cell Biol. 114:1991;545-555.
34. Jou Y.S., Layhe B., Matesic D.F., Chang C.C., et al. Inhibition of gap junctional intercellular communication and malignant transformation of rat liver epithelial cells by neu oncogene. Carcinogenesis. 16:1995;311-317.
35. Kalimi G.H., Hampton L.L., Trosko J.E., Thorgeirsson S.S., Huggett A.C. Homologous and heterologous gap-junctional intercellular communication in v-raf-, v-myc, and v-raf/v-myc-transduced rat liver epithelial cell lines. Mol. Carcinogen. 5:1992;301-310.
36. Kamibayashi Y., Oyamada Y., Mori M., Oyamada M. Aberrant expression of gap junction proteins (connexins) is associated with tumor progression during multistage mouse skin carcinogenesis in vivo. Carcinogenesis. 16:1995;1287-1297.
37. Kanematsu M.Y., Lau A.F. Epidermal worth factor stimulates the disruption of gap junctional communication and connexin 43 phosphorylation independent of 12-O-tetradecanolyphorbol 13-acetate-sensitive protein kinase C: the possible involvement of mitogen-activated protein kinase. Mol. Biol. Cell. 4:1993;837-848.
38. Katoh F., Klein J.-L., Bignami M., Yamasaki H. Association of viral oncogene-induced changes in gap junctional intercellular communication and morphological transformation in BALB/c 3T3 cells. Carcinogenesis. 14:1993;435-440.
39. Kenne K., Fransson-Steen R., Honkasalo S., Warngard L. Two inhibitors of gap junctional intercellular communication, TPA and endosulfan: different effects on phosphorylation of connexin 43 in the rat liver epithelial cell line, IAR 20. Carcinogenesis. 15:1994;1161-1165.
40. Kihara K., Fukui I., Higashi Y., Oshima H. Inhibitory effect of testosterone on gap junctional intercellular communication of human transitional cell carcinoma cell lines. Cancer Res. 50:1990;2848-2852.
41. Klann R.C., Fitzgerald D.J., Piccoli C., Slaga T.J., Yamasaki H. Characterization of gap-junctional intercellular communication in SENCAR mouse epidermal cell lines. Cancer Res. 49:1989;699-705.
42. Krutovskikh V., Yamasaki H. Ex-vivo dye transfer assay as an approach to study gap junctional intercellular communication disorders in hepatocarcinogenesis. Prog. Cell Res. 4:1995;93-97.
43. Krutovskikh V., Oyamada M., Yamasaki H. Sequential changes of gap-junctional intercellular communications during multistage rat liver carcinogenesis: direct measurement of communication in vivo. Carcinogenesis. 12:1991;1701-1706.
44. Krutovskikh V., Mazzoleni G., Mironov N., Omori Y., et al. Altered homologous and heterologous gap junctional intercellular communication in primary human liver tumors associated with aberrant protein localization but not gene mutation of connexin 32. Int. J. Cancer. 56:1994;87-94.
45. Krutovskikh V., Mesnil M., Mazzoleni G., Yamasaki H. Inhibition of rat liver gap junction intercellular communication by tumor-promoting agents in vivo; association with aberrant localization of connexin proteins. Lab. Invest. 72:1995;571-577.
46. Kurata W.E., Lau A.F. p130gag-fps disrupts gap junctional communication and induces phosphorylation of connexin 43 in a manner similar to that of pp60v-src, Oncogene. 9:1994;329-335.
47. Kwiatkowski A.P., Baker T.K., Klaunig J.E. Comparison of glucocorticoid-mediated changes in the expression and function of rat hepatocyte gap junctional proteins. Carcinogenesis. 15:1994;1753-1757.
48. Lawrence T.S., Beers W.H., Gilula N.B. Hormonal stimulation and cell communication in cocultures. Nature. 272:1978;501-506.
49. Lin Z.X., Zhang Z.Q., Yu K.R., Zhu D.G., Naus C.C.G. Increased junctional communication and forced expression of connexin 43 retards cell growth and enhances myogenic differentiation in rhabdomyosarcoma cells. Prog. Cell Res. 4:1995;31-35.
50. Loewenstein W.R. Junctional intercellular communication and the control of growth. Biochim. Biophys. Acta. 560:1979;1-65.
51. Loewenstein W.R., Penn R.D. Intercellular communication and tissue growth. II. Tissue regeneration and 33 growth. II. Tissue regeneration. J. Cell Biol. 33:1967;235-242.
52. Loo L.W., Berestecky J.M., Kanemitsu M.Y., Lau A.F. pp60src-mediated phosphorylation of connexin 43, a gap junction protein. J. Biol. Chem. 270:1995;12751-12761.
53. Madhuker B.V., Oh S.Y., Chang C.C., Wade M., Trosko J.E. Altered regulation of intercellular communication by epidermal growth factor, transforming growth factor β and peptide hormones in normal human keratinocytes. Carcinogenesis. 10:1989;13-20.
54. Mandelboim O., Berke G., Fridkin M., Feldman M., et al. CTL induction by a tumor-associated antigen octapeptide derived from a murine lung carcinoma. Nature. 369:1994;67-71.
55. Matesic D.F., Rupp H.L., Bonney W.J., Ruch R.J., Trosko J.E. Changes in gap-junction permeability, phosphorylation, and number mediated by phorbol ester and non-phorbol-ester tumor promoters in rat liver epithelial cells. Mol. Carcinohen. 10:1994;226-236.
56. Mehta P.P., Hotz-Wagenblatt A., Rose B., Shalloway D., Loewenstein W.R. Incorporation of the gene for a cell-cell channel protein into transformed cells leads to normalization of growth. J. Membr. Biol. 124:1991;207-225.
57. Mehta P.P., Yamamoto M., Rose B. Transcription of the gene for the gap junctional protein connexin 43 and expression of functional cell-to-cell channels are regulated by cAMP. Mol. Biol. Cell. 3:1992;839-850.
58. Mesnil M., Yamasaki H. Selective gap junctional communication capacity of transformed and non-transformed rat liver epithelial cell lines. Carcinogenesis. 9:1988;1499-1502.
59. Mesnil M., Montesano R., Yamasaki H. Intercellular communication of transformed and non-transformed rat liver epithelial cells. Modulation by 12-O-tetradecanoylphorbol 13-acetate. Exp. Cell Res. 165:1986;391-402.
60. Mesnil M., Fitzgerald D.J., Yamasaki H. Phenobarbital specifically reduces gap junction protein mRNA level in rat liver. Mol. Carcinogen. 1:1988;79-81.
61. Mesnil M., Piccoli C., Yamasaki H. An improved long-term culture of rat hepatocytes to detect liver tumor-promoting agents: results with phenobarbital. Eur. J. Pharmacol., Envir. Toxicol. Pharmacol. 248:1993;59-66. Section.
62. Mesnil M., Asamoto M., Piccoli C., Yamasaki H. Possible molecular mechanisms of loss of homologus and heterologous gap junctional intercellular communication in rat liver epithelial cell lines. Cell Adhes. Commun. 2:1994;377-384.
63. Mesnil M., Krutovskikh V., Piccoli C., Elfgang C., et al. Negative growth control of HeLa cells by connexin genes: connexin species specificity. Cancer Res. 55:1995;629-639.
64. Meyer R., Malewicz B., Baumann W.J., Johnson R.G. Increased gap junction assembly between cultured cells upon cholesterol supplementation. J. Cell. Sci. 96:1990;231-238.
65. Meyer R.A., Laird D.W., Revel J.P., Johnson R.G. Inhibition of gap junction and adherens junction assembly by connexin and A-CAM antibodies. J. Cell Biol. 119:1992;179-189.
66. Mironov N., Aguelon A.-M., Potapova G.I., Omori Y., et al. Alterations of (CA)n DNA repeats and tumor suppressor genes in human gastric cancer. Cancer Res. 54:1994;41-44.
67. Moreno A.P., Fishman G.I., Spray D.C. Phosphorylation shifts unitary conductance and modifies voltage dependent kinetics of human connexin 43 gap junction channels. Biophys. J. 62:1992;51-53.
68. Murray A.W., Fitzgerald D.J. Tumor promoters inhibit metabolic cooperation in cocultures of epidermal and 3T3 cells. Biochem. Biophys. Res. Commun. 91:1979;395-401.
69. Musil L.S., Goodenough D.A. Biochemical analysis of connexon assembly. Kanno Y., et al. Intercellular Communication Through Gap Junctions. Prog. Cell Res. 4:1995;327-330.
70. Naus C., Elisevich K., Zhu D., Belliveau D., Del Maestro R. In vivo growth of C6 glioma cells transfected with connexin 43 cDNA. Cancer Res. 52:1992;4208-4213.
71. Neuhaus I.M., Dahl G., Werner R. Use of alternate promoters for tissue-specific expression of the gene coding for connexin 32. Gene. 158:1995;257-262.
72. Neveu M.J., Sattler C.A., Sattler G.L., Hully J.R., et al. Differences in the expression of connexin genes in rat hepatomas in vivo and in vitro. Mol. Carcinogen. 11:1994;145-154.
73. Oelze I., Kartenbeck J., Crusius K., Alonso A. Human papillomavirus type 16 E5 protein affects cell-cell communication in an epithelial cell line. J. Virol. 69:1995;4489-4494.
74. Oyamada M., Krutovskikh V., Mesnil M., Partensky C., et al. Aberrant expression of gap junction gene in primary human hepatocellular carcinomas: increased expression of cardiac-type gap junction gene connexin 43. Mol. Carcinogen. 3:1990;273-278.
75. Oyamada Y., Oyamada M., Fusco A., Yamasaki H. Aberrant expression, function and localization of connexins in human esophageal carcinoma cell lines with different degrees of tumorigenicity. J. Cancer Res. Clin. Oncol. 120:1994;445-453.
76. Pelletier D.B., Boynton A.L. Dissociation of PDGF receptor tyrosine kinase activity from PDGF-mediated inhibition of gap junctional communication. J. Cell. Physiol. 158:1994;427-434.
77. Pitts J.D., Finbow M.E. The gap junction. J. Cell Sci. 4:(Suppl.):1986;239-266.
78. Rivedal E., Yamasaki H., Sanner T. Inhibition of gap junctional intercellular communication in Syrian hamster embryo cells by TPA, retinoic acid and DDT. Carcinogenesis. 15:1994;689-694.
79. Rose B., Mehta P.P., Loewenstein W.R. Gap-junction protein gene suppresses tumorigenicity. Carcinogenesis. 14:1993;1073-1075.
80. Rosen A., van der Merwe P.A., Davidson J.S. Effects of SV40 transformation on intercellular gap junctional communication in human fibroblasts. Cancer Res. 48:1988;3485-3489.
81. Rosen B., Mehta P.P., Loewenstein W.R. Gap-junction protein gene suppresses tumorigenicity. Carcinogenesis. 14:1993;1073-1075.
82. Saez J.C., Conner J.A., Spray D.C., Bennett M.V.L. Hepatocyte gap junctions are permeable to a second messenger, inositol 1,4,5-triphosphate and to calcium ions. Proc. Natl. Acad. Sci. USA. 86:1989;2708-2712.
83. Sakamoto H., Oyamada M., Enomoto K., Mori M. Differential changes in expression of gap junction proteins connexin 26 and 32 during hepatocarcinogenesis in rats. Jap. J. Cancer Res. 83:1992;1210-1215.
84. Sigler K., Ruch R.J. Enhancement of gap junctional intercellular communication in tumor promoter-treated cells by components of green tea. Cancer Lett. 69:1993;15-19.
85. Spray D.C., Fujita M., Saez J.C., Watanabe T., et al. Proteoglycans and glycosaminoglycans induce gap junction synthesis and function in primary liver cultures. J. Cell. Biol. 105:1987;541-551.
86. Stahl W., Nicolai S., Hanusch M., Sies H. Vitamin D influences gap junctional communication in C3H/10T 1 2 murine fibroblast cells. FEBS Lett. 352:1994;1-3.
87. Swierenga S.H.H., Yamasaki H. Performance of tests for cell transformation and gap-junction intercellular communication for detecting nongenotoxic carcinogenic activity. Vainio H., Magee P., McGregor D.B., McMichael A.J. Mechanisms of Carcinogenesis in Risk Identification. 1992;165-193 IARC, Lyon.
88. Swierenga S.H.H., Fitzgerald D.J., Yamasaki H., Piccoli C., Goldberg M. Use of primary keratinocyte cultures from plucked human hairs for analysis of gap junctional intercellular communication. Toxicol. In Vitro. 5:1991;411-418.
89. Takahashi C., Kikuchi N., Katou N., Miki T., et al. Possible anti-tumor-promoting activity of components in Japanese soybean fermented food, Natto: effect on gap junctional intercellular communication. Carcinogenesis. 16:1995;471-473.
90. Tateno C., Ito S., Tanaka M., Oyamada M., Yoshitake A. Effect of DDT on hepatic gap junctional intercellular communication in rats. Carcinogenesis. 15:1994;517-521.
91. Trosko J.E., Chang C.C. Nongenotoxic mechanisms in carcinogenesis: role of inhibited intercellular communication. Banbury Rep. 31:1988;139-170.
92. Trosko J.E., Yotti L.P., Warren S.T., et al. Inhibition of cell-cell communication by tumor promoters. Hecker E., et al. Carcinogenesis: Cocarcinogenesis and Biological Effects of Tumor Promoters. Vol. 7:1982;565-585 Raven Press, New York.
93. Ubeda A., Trillo M.A., House D.E., Blackman C.F. Melatonin enhances junctional transfer in normal C3H/10T1/2 cells. Cancer Lett. 91:1995;241-245.
94. van Zoelen E.J., Tertoolen L.G. Transforming growth factor-beta enhances the extent of intercellular communication between normal rat kidney cells. J. Biol. Chem. 266:1991;12705-12781.
95. Wilgenbus K.K., Kirkpatrick C.J., Knuechel R., Willecke K., Traub O. Expression of Cx26, Cx32 and Cx43 gap junction proteins in normal and neoplastic human tissues. Int. J. Cancer. 51:1992;522-529.
96. Yamasaki H. Gap junctional intercellular communication and carcinogenesis. Carcinogenesis. 11:1990;1051-1058.
97. Yamasaki H. Nongenotoxic mechanisms of carcinogenesis: studies of cell transformation and gap junctional intercellular communication. Toxicol. Lett. 77:1995;55-61.
98. Yamasaki H., Katoh F. Further evidence for the involvement of gap-junctional intercellular communication in induction and maintenance of transformed foci in BALB/c 3T3 cells. Cancer Res. 48:1988;3490-3495.
99. Yamasaki H., Krutovskikh V., Mesnil M., Columbano A., et al. Gap junctional intercellular communication and cell proliferation during rat liver carcinogenesis. Environ. Health Perspect. 101:(Suppl. 5):1993;191-198.
100. Yamasaki H., Mesnil M., Omori Y., Mironov N., Krutovskikh V. Aberrant control of connexin expression and functions in multistage rat and human hepatocarcinogenesis. Prog. Cell Res. 4:1995a;79-82.
101. Yamasaki H., Mesnil M., Omori Y., Mironov N., Krutovskikh V. Intercellular communication and carcinogenesis. Mutation Res. 333:1995b;181-188.
102. Yamasaki H., Ashby J., Bignami M., Jongen W., et al. Nongenotoxic carcinogens: development of detection methods based on mechanisms - a European project. Mutation Res. 1996;. (in press).
103. Yotti L.P., Chang C.C., Trosko J.E. Elimination of metabolic cooperation in Chinese hamster cells by a tumor promoter. Science. 206:1979;1089-1091.
104. Yu W., Dahl G., Werner R. The connexin 43 gene is responsive to oestrogen. Proc. R. Soc. Lond. B. Biol. Sci. 255:1994;125-132.
105. Zampighi G., Unwin P.N.T. Two forms of isolated gap junctions. J. Mol. Biol. 135:1979;451-464.
106. Zhang L.X., Cooney R.V., Bertram J.S. Carotenoids up-regulate connexin 43 gene expression independent of their provitamin A or antioxidant properties. Cancer Res. 52:1992;5707-5712.
107. Zhu D., Caveney S., Kidder G.M., Naus C.C.G. Transfection of C6 glioma cells with connexin 43 cDNA: analysis of expression, intercellular coupling and cell proliferation. Proc. Natl. Acad. Sci. USA. 88:1991;1883-1887.